Hyperbaric oxygen for carbon monoxide poisoning

被引:184
作者
Buckley, N. A. [1 ]
Juurlink, D. N. [2 ]
Isbister, G. [3 ]
Bennett, M. H. [4 ]
Lavonas, E. J. [5 ]
机构
[1] Univ NSW, Professorial Med Unit, POWH Clin Sch, Randwick, NSW 2031, Australia
[2] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[3] Newcastle Mater Misericordiae Hosp, Emergency Dept, Waratah, Australia
[4] Prince Wales Hosp, Dept Anaesthesia, Randwick, NSW 2031, Australia
[5] Denver Hlth & Hosp Author, Rocky Mt Poison & Drug Ctr, Denver, CO USA
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2011年 / 04期
关键词
Hyperbaric Oxygenation; Carbon Monoxide Poisoning [therapy; Oxygen Inhalation Therapy; Randomized Controlled Trials as Topic; Humans; CARDIOPULMONARY-RESUSCITATION; NORMOBARIC OXYGEN; SEQUELAE; TRIALS;
D O I
10.1002/14651858.CD002041.pub3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Poisoning with carbon monoxide (CO) remains an important cause of accidental and intentional injury worldwide. Several unblinded non-randomized trials have suggested that the use of hyperbaric oxygen (HBO) prevents the development of neurological sequelae. This has led to the widespread use of HBO in the management of patients with carbon monoxide poisoning. Objectives To examine randomised trials of the efficacy of hyperbaric oxygen (HBO) compared to normobaric oxygen (NBO) for the prevention of neurologic sequelae in patients with acute carbon monoxide poisoning. Search strategy We searched the following electronic databases; Cochrane Injuries Group Specialised Register (searched June 2010), Cochrane Central Register of Controlled Trials (The Cochrane Library 2010, Issue 2), MEDLINE (Ovid SP) 1950 to June 2010, EMBASE (Ovid SP) 1980 to June 2010, ISI Web of Science: Science Citation Index Expanded (SCI-EXPANDED) 1970 to June 2010, ISI Web of Science: Conference Proceedings Citation Index-Science (CPCI-S) 1990 to June 2010. Selection criteria All randomised controlled trials of HBO compared to NBO, involving non-pregnant adults who are acutely poisoned with carbon monoxide (regardless of severity). Data collection and analysis Two authors independently extracted from each trial information on: the number of randomised patients, types of participants, the dose and duration of the intervention, and the prevalence of neurologic symptoms at follow-up. Main results Seven randomised controlled trials of varying quality were identified; one was excluded because it did not evaluate clinical outcomes. Of the six remaining trials involving 1361 participants, two found a beneficial effect of HBO for the reduction of neurologic sequelae at one month, while four others did not. One of these is an incomplete publication (an abstract of an interim analysis). Although pooled random effects meta-analysis does not suggest a significant benefit from HBOT (OR for neurological deficits 0.78, 95% CI 0.54 to 1.12), significant methodologic and statistical heterogeneity was apparent among the trials, and this result should be interpreted cautiously. Moreover, design or analysis flaws were evident in all trials. Importantly, the conclusions of one positive trial may have been influenced by failure to adjust for multiple hypothesis testing, while interpretation of the other positive trial is hampered by a high risk of bias introduced during the analysis including an apparent change in the primary outcome. Both were also stopped early 'for benefit', which is likely to have inflated the observed effect. In contrast three negative trials had low power to detect a benefit of HBO due to exclusion of severely poisoned patients in two and very poor follow-up in the other. One trial that was said to be finished around eight years ago has not reported the final analysis in any forum. Authors' conclusions Existing randomised trials do not establish whether the administration of HBO to patients with carbon monoxide poisoning reduces the incidence of adverse neurologic outcomes. Additional research is needed to better define the role, if any, of HBO in the treatment of patients with carbon monoxide poisoning. This research question is ideally suited to a multi-center randomised controlled trial.
引用
收藏
页数:41
相关论文
共 45 条
  • [1] ANNANE D, 2010, HYPERBARIC OXYGEN TH
  • [2] Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials
    Annane, Djillali
    Chadda, Karim
    Gajdos, Philippe
    Jars-Guincestre, Marie-Claude
    Chevret, Sylvie
    Raphael, Jean-Claude
    [J]. INTENSIVE CARE MEDICINE, 2011, 37 (03) : 486 - 492
  • [3] [Anonymous], 2004, J TOXICOL-CLIN TOXIC
  • [4] [Anonymous], 2010, SURGERY, DOI DOI 10.1016/J.SURG.2009.06.030
  • [5] BASSLER D, 2002, JAMA-J AM MED ASSOC, V303, P1180
  • [6] BUCKLEY NA, 2005, TOXICOL REV, V24, P159
  • [7] Buckley Nicholas A, 2005, Toxicol Rev, V24, P75, DOI 10.2165/00139709-200524020-00002
  • [8] Immediate oxygen therapy prevents brain cell injury in carbon monoxide poisoned rats without loss of consciousness
    Bunc, Matjaz
    Luzar, Bostjan
    Finderle, Zarko
    Suput, Dusan
    Brvar, Miran
    [J]. TOXICOLOGY, 2006, 225 (2-3) : 138 - 141
  • [9] DUCASSE JL, 1995, UNDERSEA HYPERBAR M, V22, P9
  • [10] [高春锦 Gao Chunjin], 2002, [中华航海医学与高气压医学杂志, Chinese journal of nautical medicine and hyperbaric medicine], V9, P142